Germline transmitted DNA hypermethylation responsible for increased cancer risk was identified in the promoters of MLH1 and MSH2 in several Lynch syndrome patients [132,133,134], DAPK1 in chronic lymphocytic leukemia [135], BRCA1 in breast cancer [136] or RB1 in retinoblastoma [115]. This evidence concerns the gene MLH1 and cancer.